Srini Pharmaceuticals
Hyderabad, India· Est.
Indian CMO delivering GMP‑compliant API manufacturing with FDA‑approved facilities and robust R&D capabilities.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian CMO delivering GMP‑compliant API manufacturing with FDA‑approved facilities and robust R&D capabilities.
Technology Platform
High‑purity small‑molecule synthesis with multi‑batch GMP facilities, supported by an advanced R&D lab for process optimization and analytical development.
Opportunities
Rising global demand for outsourced API manufacturing and potential expansion into continuous flow and advanced analytics.
Risk Factors
Intense competition from other Indian CDMOs, regulatory scrutiny, and client concentration risk.
Competitive Landscape
Competes with Indian and global CDMOs; differentiates through FDA‑approved facilities, multi‑API capacity, and a strong R&D support platform.